Tag: news

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

SHANGHAI, June 13, 2026 /PRNewswire/ -- The Gala Night of the 28th Shanghai International Film Festival (SIFF) was held in Shanghai today, bringing together...

HeroMD 4-MAX Claims Evaluated: Why Men Searching “Most Effective 4-in-1 Erectile Dysfunction Formula” Are Comparing SURGE, PRIME and The HERO System Explained

HeroMD 4-MAX scam or legit? Compounded 4-in-1 sublingual ED formula with 10-min onset and 36-hr window reviewed.

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma...

セントオート、「1997年から新時代へ：フリーランダーがランドローバーのDNAを現代的デザインにどう再解釈したか」というニュース記事を掲載

北京発 , June 14, 2026 (GLOBE NEWSWIRE) -- セントオート・オートモーティブ・コミュニケーション・カンパニー (Sentauto Automotive Communication Company) は、「1997年から新時代へ：フリーランダーがランドローバーのDNAを現代的デザインにどう再解釈したか (From 1997 to a New Era: How FREELANDER Reinterprets Its Land Rover DNA into Modern Design)」というニュース記事を掲載した。記事全文はこちらからアクセス可能である： https://www.sentauto.com/news/907.html。

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma...

TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

NEW YORK, June 13, 2026 /PRNewswire/ -- Travel And Tour World (TTW) today announced its Top 50 Amusement Park Travel Destinations in the World...

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation...

NASDAQ: WGS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against GeneDx Holdings Corp. (WGS)

Did you buy WGS securities between April 16, 2025, and May 4, 2026?

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

INDIANAPOLIS, June 13, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the Phase 1 AJX-101 study showing that...

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).

EAACI Menyerukan Masa Depan “Vision Zero” yang Bebas dari Beban Alergi dan Asma

Para ahli energi terkemuka berkumpul di Istanbul untuk membahas secara lebih mendalam bagaimana sains, pencegahan, dan kebijakan dapat mengurangi dampak penyakit alergi di tingkat global

Para ahli energi terkemuka berkumpul di Istanbul untuk membahas secara lebih mendalam bagaimana sains, pencegahan, dan kebijakan dapat mengurangi dampak penyakit alergi di tingkat global

EAACI、アレルギーや喘息の負担から解放された「ビジョン・ゼロ」の未来を標榜

アレルギー分野の第一線の専門家がイスタンブールに集結し、科学、予防、政策がいかにしてアレルギー疾患の世界的な影響を軽減できるかを検討する

アレルギー分野の第一線の専門家がイスタンブールに集結し、科学、予防、政策がいかにしてアレルギー疾患の世界的な影響を軽減できるかを検討する

유럽알레르기임상면역학회 (EAACI), 알레르기·천식 부담 없는 ‘비전 제로’ 미래 제시

세계 알레르기 전문가들, 이스탄불에 모여 과학·예방·정책을 통한 질환 부담 감소 방안 논의

세계 알레르기 전문가들, 이스탄불에 모여 과학·예방·정책을 통한 질환 부담 감소 방안 논의

EAACI Seru ke Arah Masa Depan “Vision Zero” Bebas daripada Beban Alahan dan Asma

Pakar alahan terkemuka akan berhimpun di Istanbul untuk meneroka bagaimana sains, pencegahan dan dasar awam dapat mengurangkan beban global penyakit alahan

Pakar alahan terkemuka akan berhimpun di Istanbul untuk meneroka bagaimana sains, pencegahan dan dasar awam dapat mengurangkan beban global penyakit alahan

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsNews

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WGS

Canada Council for the Arts invests $25 million to strengthen Alberta arts communities

Muscle Growth Supplements Featuring Magnesium, Ashwagandha and Omega-3s Are Highlighted by PureHealth Research

Tag: news

Gala Night of the 28th Shanghai International Film Festival Held in Shanghai

HeroMD 4-MAX Claims Evaluated: Why Men Searching “Most Effective 4-in-1 Erectile Dysfunction Formula” Are Comparing SURGE, PRIME and The HERO System Explained

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

セントオート、「1997年から新時代へ：フリーランダーがランドローバーのDNAを現代的デザインにどう再解釈したか」というニュース記事を掲載

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

NASDAQ: WGS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against GeneDx Holdings Corp. (WGS)

Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

EAACI Menyerukan Masa Depan “Vision Zero” yang Bebas dari Beban Alergi dan Asma

EAACI、アレルギーや喘息の負担から解放された「ビジョン・ゼロ」の未来を標榜

유럽알레르기임상면역학회 (EAACI), 알레르기·천식 부담 없는 ‘비전 제로’ 미래 제시

EAACI Seru ke Arah Masa Depan “Vision Zero” Bebas daripada Beban Alahan dan Asma

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us